Sarepta and Roche will share the monitors' findings with EMA to resolve a temporary hold. Elsewhere, Allakos agreed to a buyout and high-dose Ocrevus missed a study goal.
Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved
HOT NEWS
Your Trusted Life Sciences Partner For High-Purity Chemicals…
Source: Greenfield Global Life sciences and biopharmaceutical development require partners that can deliver both consistency…
تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire Provides Press Release Distribution in Arabic
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…